The repopulating cancer cells in melanoma are characterized by increased mitochondrial membrane potential

Cancer Lett. 2016 Nov 28;382(2):186-194. doi: 10.1016/j.canlet.2016.08.027. Epub 2016 Sep 5.

Abstract

Although considerable effort has been expended in identifying definitive markers for cancer stem cells (CSCs) or cancer-initiating cells (CICs), the phenotypic plasticity of these cells obviates simple characterization using cell surface markers. We hypothesized that these cells could be characterized by their metabolic properties because they are in a quiescent state with low energy needs. We examined whether cancer cells differ in mitochondrial membrane potential (Δψm) when they are under stress. The Δψm of B16-F10 melanoma cells increased when they were exposed in vitro to serum starvation and chemotherapeutic agents, but not when exposed to hypoxia. Such TMREhigh cells were also present in tumor tissue. They primarily used glucose and/or lactate, and were superior to TMRElow B16-F10 cells in their ability to drive tumor growth. These findings suggest that CSCs or CICs could be identified in heterogeneous melanoma populations by measuring Δψm.

Keywords: Chemotherapeutics; Melanoma; Metabolism; Mitochondrial membrane potential; Repopulating cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Cell Proliferation*
  • Cell Survival
  • Cisplatin / pharmacology
  • Energy Metabolism
  • Female
  • Glucose / metabolism
  • Lactic Acid / metabolism
  • Melanoma, Experimental / drug therapy
  • Melanoma, Experimental / metabolism*
  • Melanoma, Experimental / pathology
  • Membrane Potential, Mitochondrial* / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondria / pathology
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / metabolism*
  • Neoplastic Stem Cells / pathology
  • Phenotype
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / pathology
  • Time Factors
  • Tumor Burden
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents
  • Lactic Acid
  • Glucose
  • Cisplatin